Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04074746
Title Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

B-cell lymphoma

mycosis fungoides

peripheral T-cell lymphoma

Hodgkin's lymphoma

anaplastic large cell lymphoma

Therapies

Cyclophosphamide + Fludarabine

AFM13

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.